High-Risk BCC Of the Lower Eyelid in Patient with Presternal Located Cutaneous Melanoma and BCC Of the Shoulder: Melolabial Advancement Flap Combined with Undermining Surgical Approach As Promising Complex One Step Treatment Option!

Authors

  • Georgi Tchernev Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, General Skobelev Nr 79, Sofia, Bulgaria; Onkoderma - Policlinic for Dermatology and Dermatologic Surgery, General Skobelev 26, Sofia, Bulgaria
  • Ilia Lozev Medical Institute of the Ministry of Interior, Surgery, Sofia, Bulgaria
  • Ivan Pidakev Medical Institute of the Ministry of Interior, Surgery, Sofia, Bulgaria
  • Irina Yungareva Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, General Skobelev Nr 79, Sofia, Bulgaria
  • Tanya Naskova-Popova Department of Clinical Hematology University Multiprofile Hospital for Active Treatment “Sveti Ivan Rilski”, 15, Acad. Ivan Geshov Blvd., Sofia 1431, Bulgaria
  • Ivanka Temelkova Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, General Skobelev Nr 79, Sofia, Bulgaria

DOI:

https://doi.org/10.3889/oamjms.2018.408

Keywords:

Melanoma, High risk BCC, Collision tumours, Melolabial flap

Abstract

BACKGROUND: It is assumed that the occurrence of keratinocyte and melanocytic tumours is multifactorial driven. Certain risk factors such as solar radiation, p53 protein and Melanocortin-1 receptor (MC1R) prove to be common to their development, which at the same time shows that their simultaneous manifestation in the same patients, for example, is quite possible. Such a manifestation could be observed as collision tumours within the same solitary lesion or as a simultaneous occurrence within two completely different lesions that are clearly distinguished from one another.

CASE REPORT: An 85-year-old patient is presented with three primary cutaneous tumours located in region presternal, infraorbital sinistra and scapularis extra. The lesions were removed during a single surgical session. For the high-risk basal cell carcinoma (BCC) in the lower eyelid, the so-called melolabial advancement flap was applied, and for the tumours located in the other two areas, the undermining surgical approach was applied. The subsequent histological analysis found that the case referred to two keratinocyte tumours (BCC) and one melanocyte tumour (cutaneous melanoma).

CONCLUSIONS: The patient presented is interesting with regard to 1) the simultaneous presentation of three primaries with different localization (so far not described in the world literature, namely 2 basal cell carcinomas and one melanoma in the same patient concurrently), 2) one of the basal cell tumours belongs to the group of high-risk (according to the localization) and meanwhile advanced BCC (according to the infiltration degree of the underlying tissue-infiltration of the musculature) and 3) their simultaneous successful surgical treatment in a single surgical session under local anaesthesia.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Rosso S, Zanetti R, Pippione M, Sancho-Garnier H. Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure. Melanoma Res. 1998; 8(6):573-83. https://doi.org/10.1097/00008390-199812000-00013 PMid:9918420

Armstrong B, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B. 2001; 63(1-3):8-18. https://doi.org/10.1016/S1011-1344(01)00198-1

Giglia-Mari G, Sarasin A. TP53 mutations in human skin cancers. Hum Mutat. 2003; 21(3):217-28. https://doi.org/10.1002/humu.10179 PMid:12619107

Shea C, McNutt N, Volkenandt M, Lugo J, Prioleau P, Albino A. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol. 1992; 141(1):25–29. PMid:1632467 PMCid:PMC1886589

Box N, Duffy D, Irving R, Russell A, Chen W, Griffyths L, Parsons P, Green A, Sturm R. Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. J Invest Dermatol. 2001; 116(2):224-9. https://doi.org/10.1046/j.1523-1747.2001.01224.x PMid:11179997

Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck J. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001; 117(2):294-300. https://doi.org/10.1046/j.0022-202x.2001.01421.x PMid:11511307

Tchernev G, Orfanos CE. Downregulation of cell cycle modulators p21, p27, p53, Rb and proapoptotic Bcl-2-related proteins Bax and Bak in cutaneous melanoma is associated with worse patient prognosis: preliminary findings. J Cutan Pathol. 2007; 34(3):247-56. https://doi.org/10.1111/j.1600-0560.2006.00700.x PMid:17302609

Fecker LF, Geilen CC, Tchernev G, Trefzer U, Assaf C, Kurbanov BM, Schwarz C, Daniel PT, Eberle J. Loss of proapoptotic Bcl-2-related multidomain proteins in primary melanomas is associated with poor prognosis. J Invest Dermatol. 2006; 126(6):1366-71. https://doi.org/10.1038/sj.jid.5700192 PMid:16528364

Koseoglu RD, Sezer E, Eyibilen A, Aladag I, Etikan I. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas. J Cutan Pathol. 2009; 36(9):958-65. https://doi.org/10.1111/j.1600-0560.2009.01204.x PMid:19187116

Hagedorn M, RuBwurm R, Sommer B, Thomas C. Simultaneous Occurrence Of A Basal Cell Carcinoma, Squamous Cell Carcinoma And Malignant Melanoma In A Patient. The American Journal of Dermatopathology. 1994; 16(1):101. https://doi.org/10.1097/00000372-199402000-00043

Grampurohit V, Dinesh U, Rao R. Multiple cutaneous malignancies in a patient of xeroderma pigmentosum. J Cancer Res Ther. 2011; 7(2):205-7. https://doi.org/10.4103/0973-1482.82932 PMid:21768716

Medeiros P, Alves N, Silva C, Faria P, Barcaui C, Pi-eiro-Maceira J. Collision of malignant neoplasms of the skin: basosquamous cell carcinoma associated with melanoma. An Bras Dermatol. 2015; 90(3 Suppl 1):39–42. https://doi.org/10.1590/abd1806-4841.20153845 PMid:26312670 PMCid:PMC4540504

Nakahara H, Kitamura R, Shirasuna K. Simultaneous malignant melanoma and squamous cell carcinoma of the oral cavity: a case report. J Oral Maxillofac Surg. 1995; 53(12):1455-7. https://doi.org/10.1016/0278-2391(95)90676-2

Mancebo S, Marchetti M, Hollmann T, Marghoob A Busam K, Halpern A. Melanoma in situ colonizing basal cell carcinoma: a case report and review of the literature. Dermatol Pract Concept. 2015; 5(1):25–30. https://doi.org/10.5826/dpc.0501a04 PMid:25692077 PMCid:PMC4325687

King R, Lyons J, Meyers A, Googe P, Page R, Gupta V. Primary invasive melanoma and basal cell carcinoma (collision tumor) with blue nevus-like cutaneous metastases. J Cutan Pathol. 2007; 34(8):629-33. https://doi.org/10.1111/j.1600-0560.2006.00677.x PMid:17640233

Braun-Falco M. Combined malignant melanoma and basal cell carcinoma tumor of the intermingled type. J Cutan Pathol. 2007; 34(9):731-5. https://doi.org/10.1111/j.1600-0560.2006.00703.x PMid:17696923

Burkhalter A, White W. Malignant melanoma in situ colonizing basal cell carcinoma. A simulator of invasive melanoma. Am J Dermatopathol. 1997; 19(3):303–7. https://doi.org/10.1097/00000372-199706000-00019 PMid:9185921

Wang H, Benda P, Piepkorn M. Parasitism of basal cell carcinoma by lentigo maligna melanoma. J Am Acad Dermatol. 2003; 48(5 Suppl):S92–4. https://doi.org/10.1067/mjd.2003.237 PMid:12734489

Goeser M, Dimaio D. A colonization of basal cell carcinoma by malignant melanoma in situ resembling a malignant basomelanocytic tumor. Am J Dermatopathol. 2014; 36(11):e179–82. https://doi.org/10.1097/DAD.0000000000000047 PMid:24752214

Miteva M, Herschthal D, Ricotti C. A rare case of a cutaneous squamomelanocytic tumor: revisiting the histogenesis of combined neoplasms. Am J Dermatopathol. 2009; 31(6):599–603. https://doi.org/10.1097/DAD.0b013e3181a88116 PMid:19590411

Erickson L, Myers J, Mihm M. Malignant basomelanocytic tumor manifesting as metastatic melanoma. Am J Surg Pathol. 2004; 28(10):1393–96. https://doi.org/10.1097/01.pas.0000135526.19189.31 PMid:15371958

Cornejo K, Deng A. Malignant melanoma within squamous cell carcinoma and basal cell carcinoma: is it a combined or collision tumor?--a case report and review of the literature. Am J Dermatopathol. 2013; 35(2):226-34. https://doi.org/10.1097/DAD.0b013e3182545e27 PMid:22588546

Sharma S, Agrawal U, Gupta P, Bhatnagar A, Jairajpuri Z. Malignant melanoma and basal cell carcinoma of the face: a rare coexistence. Ann Saudi Med. 2013; 33(3):304-6. https://doi.org/10.5144/0256-4947.2013.304 PMid:23793437 PMCid:PMC6078527

van der Leest R, Hollestein L, Liu L, Nijsten T, de Vries E. Risks of different skin tumour combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population-based cohorts: 1989-2009. J Eur Acad Dermatol Venereol. 2018; 32(3):382-389. https://doi.org/10.1111/jdv.14587 PMid:28898461

van der Leest R, Flohil S, Arends L, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior melanoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2015; 29(6):1053-62. https://doi.org/10.1111/jdv.12887 PMid:25491923

Flohil S, van der Leest R, Arends L, de Vries E, Nijsten T. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer. 2013; 49(10):2365-75. https://doi.org/10.1016/j.ejca.2013.03.010 PMid:23608733

Frisch M, Hjalgrim H, Olsen J, Melbye M. Risk for subsequent cancer after diagnosis of basal-cell carcinoma. A population-based, epidemiologic study. Ann Intern Med. 1996; 125(10):815-21. https://doi.org/10.7326/0003-4819-125-10-199611150-00005 PMid:8928988

Yalcin O, Sezer E, Kabukcuoglu F, Kilic A, Sari A, Cerman A, Altunay I. Presence of ulceration, but not high risk zone location, correlates with unfavorable histopathological subtype in facial basal cell carcinoma. Int J Clin Exp Pathol. 2015; 8(11):15448–15453. PMid:26823913 PMCid:PMC4713699

Wollina U, Steinbach F, Verma S, Tchernev G. Penile tumours: a review. Journal of the European Academy of Dermatology and Venereology. 2014; 28(10):1267-76. https://doi.org/10.1111/jdv.12491 PMid:24684236

Choi J, Kim Y, Kim H, Nam S, Woong Y. Distribution of Basal Cell Carcinoma and Squamous Cell Carcinoma by Facial Esthetic Unit. Arch Plast Surg. 2013; 40(4):387–391. https://doi.org/10.5999/aps.2013.40.4.387 PMid:23898436 PMCid:PMC3724000

Published

2018-11-21

How to Cite

1.
Tchernev G, Lozev I, Pidakev I, Yungareva I, Naskova-Popova T, Temelkova I. High-Risk BCC Of the Lower Eyelid in Patient with Presternal Located Cutaneous Melanoma and BCC Of the Shoulder: Melolabial Advancement Flap Combined with Undermining Surgical Approach As Promising Complex One Step Treatment Option!. Open Access Maced J Med Sci [Internet]. 2018 Nov. 21 [cited 2024 Mar. 28];6(11):2147-51. Available from: https://oamjms.eu/index.php/mjms/article/view/oamjms.2018.408

Issue

Section

C- Case Reports

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>